Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5397
-0.0556 %
$ 23 M
Market Cap
-3.17
P/E
ADAP - OTHER CURRENT LIABILITIES
Other Current Liabilities ADAP - Adaptimmune Therapeutics plc
28.9 M
LAST VALUE
2.36%
2 YEAR CAGR
7.27%
5 YEAR CAGR
-5.43%
10 YEAR CAGR